Cancer Patient Risk of DVT/PE vs. Awareness and Information
Despite being at increased risk, the results of the NBCA DVT/PE Awareness survey demonstrate that oncology patient awareness of DVT risk factors is low. When asked to identify or name DVT risk factors, just 8% of all oncology patients identify surgery, and just 4% identify chemotherapy, radiation, or some form of cancer treatment as risk factors. In addition, just 86 of the total 500 oncology patients surveyed report that they can name PE signs or symptoms, with 69% of this small group citing breathing difficulty, 28% chest tightness, and 5% coughing up blood.
NBCA conducted its DVT/PE Awareness Survey in direct response to the Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. The survey objectives were to measure DVT/PE awareness among patients with cancer and to identify gaps in DVT/PE prophylaxis reported by these patients. The survey results show the need to improve dialogue between cancer patients and their physicians about DVT/PE risk factors and prevention.
The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.